AU7767598A - Salts of aromatic sulphonic acids - Google Patents

Salts of aromatic sulphonic acids Download PDF

Info

Publication number
AU7767598A
AU7767598A AU77675/98A AU7767598A AU7767598A AU 7767598 A AU7767598 A AU 7767598A AU 77675/98 A AU77675/98 A AU 77675/98A AU 7767598 A AU7767598 A AU 7767598A AU 7767598 A AU7767598 A AU 7767598A
Authority
AU
Australia
Prior art keywords
salt
aromatic
methyl
oxepino
dibenz
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU77675/98A
Other languages
English (en)
Inventor
Gerardus Johannes Heeres
Franciscus Hermanus Antonius Adreana Van Bakel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of AU7767598A publication Critical patent/AU7767598A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU77675/98A 1997-05-26 1998-05-19 Salts of aromatic sulphonic acids Abandoned AU7767598A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97201596 1997-05-26
EP97201596 1997-05-26
PCT/EP1998/003022 WO1998054186A1 (en) 1997-05-26 1998-05-19 Salts of aromatic sulphonic acids

Publications (1)

Publication Number Publication Date
AU7767598A true AU7767598A (en) 1998-12-30

Family

ID=8228372

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77675/98A Abandoned AU7767598A (en) 1997-05-26 1998-05-19 Salts of aromatic sulphonic acids

Country Status (12)

Country Link
EP (1) EP0984968A1 (ko)
JP (1) JP2001526702A (ko)
KR (1) KR20010012985A (ko)
CN (1) CN1257504A (ko)
AU (1) AU7767598A (ko)
BR (1) BR9809162A (ko)
CA (1) CA2290070A1 (ko)
HU (1) HUP0002106A3 (ko)
NO (1) NO995770D0 (ko)
PL (1) PL337027A1 (ko)
TR (1) TR199902727T2 (ko)
WO (1) WO1998054186A1 (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5067998B2 (ja) 2001-10-30 2012-11-07 ノバルティス アーゲー イロペリドンおよび星形ポリマーのデポー製剤
HRP20020440B1 (en) 2002-05-21 2008-02-29 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
HRP20020452A2 (en) 2002-05-23 2004-02-29 Pliva D D 1,2-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof
GB0216416D0 (en) * 2002-07-15 2002-08-21 Novartis Ag Organic compounds
MX2007004485A (es) * 2004-10-15 2007-06-13 Organon Nv Tratamiento de desordenes bipolares y sintomas asociados.
TW201113018A (en) 2009-06-24 2011-04-16 Organon Nv Injectable formulations containing asenapine and method of treatment using same
ITMI20110734A1 (it) 2011-05-02 2012-11-03 Olon Spa Sali cristallini di asenapina
EP2524920A1 (en) 2011-05-17 2012-11-21 Sandoz AG Novel Crystalline Asenapine Hydrochloride Salt Forms
EP2524919A1 (en) 2011-05-17 2012-11-21 Sandoz AG Novel crystalline salts of Asenapine with organic Di-acids and Tri-acids
EP2524921A1 (en) 2011-05-17 2012-11-21 Sandoz AG Novel Crystalline Salts of Asenapine
MX2019007391A (es) 2016-12-20 2019-08-16 Lts Lohmann Therapie Systeme Ag Sistema terapeutico transdermico que contiene asenapina.
EP3558276A1 (en) 2016-12-20 2019-10-30 LTS Lohmann Therapie-Systeme AG Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
WO2019002204A1 (en) 2017-06-26 2019-01-03 Lts Lohmann Therapie-Systeme Ag TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE AND SILICONE-TYPE ACRYLIC HYBRID POLYMER
WO2019243452A1 (en) 2018-06-20 2019-12-26 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7605526A (nl) * 1976-05-24 1977-11-28 Akzo Nv Nieuwe tetracyclische derivaten.

Also Published As

Publication number Publication date
NO995770L (no) 1999-11-25
PL337027A1 (en) 2000-07-31
HUP0002106A2 (hu) 2000-11-28
NO995770D0 (no) 1999-11-25
WO1998054186A1 (en) 1998-12-03
HUP0002106A3 (en) 2001-11-28
BR9809162A (pt) 2000-08-01
KR20010012985A (ko) 2001-02-26
JP2001526702A (ja) 2001-12-18
EP0984968A1 (en) 2000-03-15
CN1257504A (zh) 2000-06-21
TR199902727T2 (xx) 2000-07-21
CA2290070A1 (en) 1998-12-03

Similar Documents

Publication Publication Date Title
AU7767598A (en) Salts of aromatic sulphonic acids
TWI297011B (en) Dpp-iv inhibitors
AU1186795A (en) Inhibition of smooth muscle migration and proliferation with hydroxy carbazole compounds
SK3898A3 (en) Cyclic gmp-specific phosphodiesterase inhibitors
CA2734780C (en) Short acting benzothiazepine calcium channel blockers and uses thereof
KR20010087361A (ko) [1,2,4]트리아졸로[1,5-ｃ]피리미딘 유도체
US5426106A (en) Pyrrolo-pyridazinone derivatives
US4694010A (en) Anticonvulsant compositions and method
DE69923587T2 (de) Nichtpeptidische antagonisten des glp-1 rezeptors und verwendungsmethoden
JPH01146821A (ja) ペルゴリド化合物の安定化
JPH11507030A (ja) 抗精神病薬としてのベンゾイソオキサゾール及びインダゾール誘導体
PT87716B (pt) Processo para a preparacao de cicloalquilamidas de (8 beta)-1-alquil-6-(substituidas)ergolinas
DE102005061171A1 (de) Neue, cyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung
JP2974351B2 (ja) プロドラッグとしての６―クロロ―７，８―ジヒドロキシ―１―（４’―ヒドロキシフェニル）―２，３，４，５―テトラヒドロ―１ｈ―３―ベンズアゼピンのカルバメート
DE69925250T2 (de) Aktivatoren der kalium-kanäle
EP0178201A1 (fr) Dérivés de furo [3,2-c]pyridines, leur préparation et leur application en thérapeutique
US6806283B2 (en) Selective serotonin receptor antagonists and therapeutic applications thereof
MXPA99010901A (en) Salts of aromatic sulphonic acids
MXPA03005884A (es) Hemimaleato de amlodipina.
FR2501687A1 (fr) Derives basiques de composes tricycliques et procedes pour leur preparation
KR100287933B1 (ko) 5-ht3-수용체 길항제로서의 2,6-메타노-2h-퀴놀리진 유도체,이의 제조방법 및 이를 포함하는 약제학적 조성물
CZ286649B6 (cs) 2-(aminomethyl)-3,4,7,9-tetrahydro-2H-pyrano-/2,3-e/indol-8-onové deriváty a farmaceutický prostředek s jejich obsahem
EP0022330B1 (en) Synergistic antihypertensive compositions
KR920000763B1 (ko) 신규 벤조디아제핀의 제조 방법
TW381091B (en) Cyclic sulfones, the preparation process thereof, and the pharmaceutical composition comprising the same

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted